Home NDC 59572-410 Revlimid
Product NDC 59572-410
11-digit product format 595720410
Labeler code 59572
Product ID 59572-410_b5eadec8-aa2b-43ec-b0d6-e5b0c3da08cb
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Lenalidomide
Dosage form CAPSULE
Route ORAL
Labeler Celgene Corporation
Application NDA021880
Marketing category NDA
Marketing start 2005-12-27
Substance LENALIDOMIDE
Active strength 10 mg/1
Pharmacologic classes Thalidomide Analog [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 6 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021880-001 REVLIMID LENALIDOMIDE 5MG CAPSULE / ORAL AB RLD 2005-12-27 N021880-002 REVLIMID LENALIDOMIDE 10MG CAPSULE / ORAL AB RLD 2005-12-27 N021880-003 REVLIMID LENALIDOMIDE 15MG CAPSULE / ORAL AB RLD 2006-06-29 N021880-004 REVLIMID LENALIDOMIDE 25MG CAPSULE / ORAL AB RLD, RS 2006-06-29 N021880-005 REVLIMID LENALIDOMIDE 2.5MG CAPSULE / ORAL AB RLD 2011-12-21 N021880-006 REVLIMID LENALIDOMIDE 20MG CAPSULE / ORAL AB RLD 2013-06-05
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 6 matching rows.
Orange Book patents# Current patent rows page 1 of 1 · 12 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N021880-001 7465800 2027-04-27 Drug substance, Drug product N021880-001 8741929 2028-03-08 U-1983 2014-06-17 N021880-002 7465800 2027-04-27 Drug substance, Drug product N021880-002 8741929 2028-03-08 U-1983 2014-06-17 N021880-003 7465800 2027-04-27 Drug substance, Drug product N021880-003 8741929 2028-03-08 U-1983 2014-06-17 N021880-004 7465800 2027-04-27 Drug substance, Drug product N021880-004 8741929 2028-03-08 U-1983 2014-06-17 N021880-005 7465800 2027-04-27 Drug substance, Drug product 2012-01-17 N021880-005 8741929 2028-03-08 U-1983 2014-06-17 N021880-006 7465800 2027-04-27 Drug substance, Drug product N021880-006 8741929 2028-03-08 U-1983 2014-06-17
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 12 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 7 · 246 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N021880-001 REVLIMID 5MG CAPSULE / ORAL AB RLD 2005-12-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021880-002 REVLIMID 10MG CAPSULE / ORAL AB RLD 2005-12-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021880-003 REVLIMID 15MG CAPSULE / ORAL AB RLD 2006-06-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021880-004 REVLIMID 25MG CAPSULE / ORAL AB RLD, RS 2006-06-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021880-005 REVLIMID 2.5MG CAPSULE / ORAL AB RLD 2011-12-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021880-006 REVLIMID 20MG CAPSULE / ORAL AB RLD 2013-06-05 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021880-001 REVLIMID 5MG CAPSULE / ORAL AB RLD 2005-12-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021880-002 REVLIMID 10MG CAPSULE / ORAL AB RLD 2005-12-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021880-003 REVLIMID 15MG CAPSULE / ORAL AB RLD 2006-06-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021880-004 REVLIMID 25MG CAPSULE / ORAL AB RLD, RS 2006-06-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021880-005 REVLIMID 2.5MG CAPSULE / ORAL AB RLD 2011-12-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021880-006 REVLIMID 20MG CAPSULE / ORAL AB RLD 2013-06-05 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021880-001 REVLIMID 5MG CAPSULE / ORAL AB RLD 2005-12-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021880-002 REVLIMID 10MG CAPSULE / ORAL AB RLD 2005-12-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021880-003 REVLIMID 15MG CAPSULE / ORAL AB RLD 2006-06-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021880-004 REVLIMID 25MG CAPSULE / ORAL AB RLD, RS 2006-06-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021880-005 REVLIMID 2.5MG CAPSULE / ORAL AB RLD 2011-12-21 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021880-006 REVLIMID 20MG CAPSULE / ORAL AB RLD 2013-06-05 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021880-001 REVLIMID 5MG CAPSULE / ORAL AB RLD 2005-12-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021880-002 REVLIMID 10MG CAPSULE / ORAL AB RLD 2005-12-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021880-003 REVLIMID 15MG CAPSULE / ORAL AB RLD 2006-06-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021880-004 REVLIMID 25MG CAPSULE / ORAL AB RLD, RS 2006-06-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021880-005 REVLIMID 2.5MG CAPSULE / ORAL AB RLD 2011-12-21 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021880-006 REVLIMID 20MG CAPSULE / ORAL AB RLD 2013-06-05 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021880-001 REVLIMID 5MG CAPSULE / ORAL AB RLD 2005-12-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021880-002 REVLIMID 10MG CAPSULE / ORAL AB RLD 2005-12-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021880-003 REVLIMID 15MG CAPSULE / ORAL AB RLD 2006-06-29 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021880-004 REVLIMID 25MG CAPSULE / ORAL AB RLD, RS 2006-06-29 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021880-005 REVLIMID 2.5MG CAPSULE / ORAL AB RLD 2011-12-21 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021880-006 REVLIMID 20MG CAPSULE / ORAL AB RLD 2013-06-05 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021880-001 REVLIMID 5MG CAPSULE / ORAL AB RLD 2005-12-27 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021880-002 REVLIMID 10MG CAPSULE / ORAL AB RLD 2005-12-27 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021880-003 REVLIMID 15MG CAPSULE / ORAL AB RLD 2006-06-29 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021880-004 REVLIMID 25MG CAPSULE / ORAL AB RLD, RS 2006-06-29 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021880-005 REVLIMID 2.5MG CAPSULE / ORAL AB RLD 2011-12-21 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021880-006 REVLIMID 20MG CAPSULE / ORAL AB RLD 2013-06-05 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021880-001 REVLIMID 5MG CAPSULE / ORAL AB RLD 2005-12-27 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021880-002 REVLIMID 10MG CAPSULE / ORAL AB RLD 2005-12-27 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021880-003 REVLIMID 15MG CAPSULE / ORAL AB RLD 2006-06-29 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021880-004 REVLIMID 25MG CAPSULE / ORAL AB RLD, RS 2006-06-29 2680178bc6a6…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 5 · 198 observed states.
Observed Orange Book patent history# Patent history page 1 of 74 · 2,922 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N021880-001 7465800 2027-04-27 Drug substance, Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021880-001 8741929 2028-03-08 U-1983 2014-06-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021880-002 7465800 2027-04-27 Drug substance, Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021880-002 8741929 2028-03-08 U-1983 2014-06-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021880-003 7465800 2027-04-27 Drug substance, Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021880-003 8741929 2028-03-08 U-1983 2014-06-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021880-004 7465800 2027-04-27 Drug substance, Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021880-004 8741929 2028-03-08 U-1983 2014-06-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021880-005 7465800 2027-04-27 Drug substance, Drug product 2012-01-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021880-005 8741929 2028-03-08 U-1983 2014-06-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021880-006 7465800 2027-04-27 Drug substance, Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021880-006 8741929 2028-03-08 U-1983 2014-06-17 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021880-001 7465800 2027-04-27 Drug substance, Drug product 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021880-001 8741929 2028-03-08 U-1983 2014-06-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021880-002 7465800 2027-04-27 Drug substance, Drug product 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021880-002 8741929 2028-03-08 U-1983 2014-06-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021880-003 7465800 2027-04-27 Drug substance, Drug product 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021880-003 8741929 2028-03-08 U-1983 2014-06-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021880-004 7465800 2027-04-27 Drug substance, Drug product 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021880-004 8741929 2028-03-08 U-1983 2014-06-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021880-005 7465800 2027-04-27 Drug substance, Drug product 2012-01-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021880-005 8741929 2028-03-08 U-1983 2014-06-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021880-006 7465800 2027-04-27 Drug substance, Drug product 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021880-006 8741929 2028-03-08 U-1983 2014-06-17 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021880-001 7465800 2027-04-27 Drug substance, Drug product 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021880-001 8741929 2028-03-08 U-1983 2014-06-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021880-002 7465800 2027-04-27 Drug substance, Drug product 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021880-002 8741929 2028-03-08 U-1983 2014-06-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021880-003 7465800 2027-04-27 Drug substance, Drug product 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021880-003 8741929 2028-03-08 U-1983 2014-06-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021880-004 7465800 2027-04-27 Drug substance, Drug product 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021880-004 8741929 2028-03-08 U-1983 2014-06-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021880-005 7465800 2027-04-27 Drug substance, Drug product 2012-01-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021880-005 8741929 2028-03-08 U-1983 2014-06-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021880-006 7465800 2027-04-27 Drug substance, Drug product 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021880-006 8741929 2028-03-08 U-1983 2014-06-17 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021880-001 7465800 2027-04-27 Drug substance, Drug product fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021880-001 8741929 2028-03-08 U-1983 2014-06-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021880-002 7465800 2027-04-27 Drug substance, Drug product fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021880-002 8741929 2028-03-08 U-1983 2014-06-17 fd3edfee7708…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 27 · 1,062 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Revlimid
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength LENALIDOMIDE 10 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination F0P408N6V4 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 12 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 602910 Internal RxNorm lookup 602912 Internal RxNorm lookup 616114 Internal RxNorm lookup 616116 Internal RxNorm lookup 643712 Internal RxNorm lookup 643714 Internal RxNorm lookup 643720 Internal RxNorm lookup 643722 Internal RxNorm lookup 1242231 Internal RxNorm lookup 1242233 Internal RxNorm lookup 1428947 Internal RxNorm lookup 1429367 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 59572-410-00 Revlimid 100 in 1 BOTTLE CAPSULE 100 40 59572-410-28 Revlimid 28 in 1 BOTTLE CAPSULE 28 40
DailyMed Socrata Ingredients# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 59572-410 REVLIMID (LENALIDOMIDE) CAPSULE [CELGENE CORPORATION] 40 Current NDC, Legacy NDC, 2 package rows 20230408_5fa97bf5-28a2-48f1-8955-f56012d296be.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 59572-410-00 59572041000 100 CAPSULE in 1 BOTTLE (59572-410-00) 100 capsule 2005-12-27 0000-00-00 No No Current 59572-410-28 59572041028 28 CAPSULE in 1 BOTTLE (59572-410-28) 28 capsule 2009-03-03 0000-00-00 No No Current